|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.33 USD | -0.51% |
|
+4.46% | +7.65% |
| Jan. 12 | Incyte Corporation Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-12-2026 08:15 AM | |
| Jan. 08 | Incyte Insider Sold Shares Worth $1,184,064, According to a Recent SEC Filing | MT |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- INCY Stock
- ETFs Incyte Corporation
Select your edition
All financial news and data tailored to specific country editions
